ABBOTT LABORATORIES acquires Guidant's vascular intervention and endovascular businesses
The deal at a glance
ABBOTT LABORATORIES acquired Guidant's vascular intervention and endovascular businesses for approximately $4.1 billion (acquired from Boston Scientific in connection with its acquisition of Guidant), a transaction completed in April 2006, structured as combination (cash plus a loan and milestone payments). The deal was a Carve-out.
Guidant's vascular intervention and endovascular businesses operates in Medical devices — vascular intervention, is based in Santa Clara, California, USA. Guidant's vascular intervention and endovascular solutions businesses, including coronary and peripheral stent and angioplasty product lines, acquired from Boston Scientific as a condition of Boston Scientific's acquisition of Guidant.
Combination of Abbott's and Guidant's vascular organizations creates a stronger vascular business and gives Abbott a leading position in vascular intervention.
Established Abbott as a major player in the global vascular intervention market with a drug-eluting stent pipeline. Became Abbott Vascular
No advisory firms have been disclosed for this transaction.